Brian Tanquelet
speaker
13 appearances
3 recordings
1 series
first heard May 2026
last heard 12 May
Brian Tanquelet’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 3 in all, peaking in May 2026 with 3.
Appearances
The company has been moving away from copycat versions of weight loss medications that help fuel its growth, instead prioritizing partnerships with brand name products.
Brian Tanquelet is research analyst at Jefferies.
Revenue came in at $608 million.
That was below the average analyst's estimate of $617.5 million.
In New York, Charlie Pellett, Bloomberg Radio.
The company has been moving away from copycat versions of weight loss medications that help fuel its growth, instead prioritizing partnerships with brand name products.
Brian Tanquelet is research analyst at Jefferies.
Revenue came in at $608 million.
That was below the average analyst's estimate of $617.5 million.
In New York, Charlie Pellett, Bloomberg Radio.
You certainly ask interesting questions.
What happened was that earlier this year, HIMSS signed an agreement with Novo Nordisk to basically say we're going to stop compounding or making our own versions of GLPs.
and we're just going to distribute a Novo Nordisk brand.
Showing 1–13 of 13